| Literature DB >> 34746870 |
Masood Sepehrimanesh1, Masuma Akter1, Baojin Ding1.
Abstract
Generation of patient-derived neurons provides an unprecedented approach in modeling neurological diseases. Here, we describe the direct conversion of adult fibroblasts into motor neurons via lentiviral delivery of transcription factors. Compared with iPSC-based approach, directly converted neurons from donors retain features associated with age, making them ideal systems for modeling age-related neurological diseases. Low yield is the major challenge of this protocol. High quality lentiviruses and optimized cell culture conditions are critical to improve the final yield. For complete details on the use and execution of this protocol, please refer to Ding et al. (2020), Ding et al. (2021), and Liu et al. (2016).Entities:
Keywords: Cell Biology; Cell culture; Developmental biology; Neuroscience; Tissue Engineering
Mesh:
Substances:
Year: 2021 PMID: 34746870 PMCID: PMC8554625 DOI: 10.1016/j.xpro.2021.100917
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1Lentivirus preparation and titration
(A) HEK cells at transfection with ∼80% confluency.
(B) At virus collection (72 h post-transfection) almost all HEK cells are transfected positive (plasmid #1 with co-expressed GFP).
(C) Virus titration with undiluted virus (#1) at 72 h post-transduction (> 90% cells are GFP positive).
(D) Virus titration with 1:10 diluted virus (#1) at 72 h post-transduction (∼40% cells are positive).
(E) Virus titration of undiluted virus (#2) at 72 h post-transduction with immunocytochemistry (ICC) of ISL1 (∼90% cells are positive).
(F) Virus titration with 1:10 diluted virus (#2) at 72 h post-transduction with ICC of ISL1 (∼40% cells are positive). From A to F, scale bares, 100 μm.
Figure 2Transduction of human fibroblasts with proper amount of lentiviruses
Micrographs of fibroblast cells (GM04506) transduced with lentivirus expressing reprogramming factors with indicated MOI (Multiplicity of Infection) at 3 days post-viral infection (dpi). The transduced positive cells can be identified with co-expressed GFP. Scale bars: 400 μm.
Figure 3Representative morphology of fibroblasts and directly induced motor neurons (diMNs) at indicated weeks post-viral infection (wpi)
Transduced cells are identified with co-expressed green fluorescent protein (GFP) at early time points (0.5 and 2 wpi). Transduced fibroblasts gradually become neuron-like morphology within 2 wpi. More complicated branches and very long axons can be detected at late developmental stages with immunostaining of tubulin Beta 3 Class III (TUBB3). Scale bars: 100 μm. Adapted from (Ding et al., 2020) with permission.
Figure 4Neuronal identity verification
(A) Confocal micrograph shows the highly expressed nuclear HB9 (motor neuron and pancreas homeobox 1, the early MN marker) at 2 wpi. The inset shows the nuclear HB9 alone. DNA dye hoechst33342 (HST) stained nuclei. Scale bar: 20 μm.
(B) Confocal micrographs show the robust expression of the mature MN marker CHAT (choline acetyltransferase) at 8 wpi. Scale bar: 20 μm.
(C) Quantification of the reprogramming efficiency was shown as the percentage of GFP (+) cells expressed TUBB3.
(D) Fractions of diMNs among the reprogrammed neurons was shown as the percentage of TUBB3 (+) cells expressed HB9.
(E) Fractions of diMNs among the reprogrammed neurons was shown as the percentage of TUBB3 (+) cells expressed CHAT. From C to E, data are presented as mean ± SEM. More than 300 cells of each line were counted from triplicates.
Adapted from (Ding et al., 2020, 2021) with permission.
Figure 5Micrograph shows the robust expression of the presynaptic marker synapsin 1 (SYN1) at 9 wpi
The inset shows discrete SYN1-positive puncta (indicated by arrow heads). DNA dye hoechst33342 (HST) stained nuclei. Scale bar: 50 μm. Adapted from (Ding et al., 2021) with permission.
| REAGENT and RESOURCES | SOURCE | IDENTIFIER |
|---|---|---|
| Human embryonic kidney (HEK) 293T cells | American Type Culture Collection | ATCC Cat# CRL-3216, RRID:CVCL_0063 |
| Healthy skin fibroblasts | Coriell Institute for Medical Research | Coriell Cat# GM04506, RRID:CVCL_7413 |
| Healthy skin fibroblasts | Coriell Institute for Medical Research | Coriell Cat# GM03652, RRID:CVCL_7397 |
| Healthy skin fibroblasts | Coriell Institute for Medical Research | Coriell Cat# GM08400, RRID:CVCL_7483 |
| Mouse Primary Astrocytes | N/A | N/A |
| Fetal Bovine Serum (FBS) | Corning | Cat# 35-010-CV |
| Penicillin/Streptomycin (Pen/Strep) | Thermo Fisher Scientific | Cat# 15140122 |
| Dulbecco's Modified Eagle Medium (DMEM) | Thermo Fisher Scientific | Cat# 11995073 |
| DMEM/nutrient mixture F-12 (DMEM-F12) with HEPES; without L-glutamine | Cytiva | Cat# SH30126.01 |
| Neurobasal medium | Thermo Fisher Scientific | Cat# 21103049 |
| Gelatin | Bio-Rad | Cat# 118860A |
| Matrigel | Corning | Cat# 354230 |
| B-27 Supplement (50 | Invitrogen | Cat# 17504044 |
| N-2 Supplement (100 | Invitrogen | Cat# 17502001 |
| Forskolin (FSK) | Sigma Aldrich | Cat# F6886 |
| Dorsomorphin (DM) | EMD Millipore | Cat# 171260 |
| Heat Stable Recombinant Human Basic Fibroblast Growth Factor (bFGF) | Gibco | Cat#PHG0367 |
| Brain Derived Neurotrophic Factor (BDNF) | PeproTech | Cat# 450-02 |
| Glial-Derived Neurotrophic Factor (GDNF) | PeproTech | Cat# 450-10 |
| Neurotrophin-3 (NT3) | PeproTech | Cat# 450-03 |
| Bovine serum albumin (BSA) | Thermo Fisher Scientific | Cat# bp9706 |
| Hoechst 33342 (HST) | Thermo Fisher Scientific | Cat# H3570 |
| Triton X-100 (TX-100) | Thermo Fisher Scientific | Cat# 85111 |
| Paraformaldehyde (PFA) | Sigma Aldrich | Cat# 158127 |
| Trypsin-EDTA (0.25%) | Thermo Fisher Scientific | Cat# 25200056 |
| Polyethyleneimine (PEI), 25 kDa linear | Polysciences | Cat# 23966-2 |
| Polybrene (Hexadimethrine bromide) | Sigma Aldrich | Cat# H9268-10g |
| Ara-C (Arabinosylcytosine) | Sigma Aldrich | Cat# C1768 |
| Antifade Mounting Medium | Vector Laboratories | Cat#H-1400-10 |
| Na2HPO4 | Sigma Aldrich | Cat# S-0876 |
| NaCl | Thermo Fisher Scientific | Cat# S271-10 |
| KCl | Thermo Fisher Scientific | Cat# P-217 |
| K2HPO4.3H2O | Sigma Aldrich | Cat# P-5504 |
| PVA mountain medium | N/A | N/A |
| DMSO, Dimethyl Sulfoxide | Thermo Fisher Scientific | Cat# D1391 |
| Rabbit anti-tubulin Beta 3 Class III (TUBB3), monoclonal (1:2000) | BioLegend | BioLegend Cat# 801201, RRID: |
| Chicken anti-microtubule-associated protein 2 (MAP2) (1:10,000), polyclonal | BioLegend | Cat# 822501, RRID: |
| Goat anti-CHAT, monoclonal (1:200) | Millipore | Millipore Cat# AB144P, RRID: |
| Rabbit anti-SYN1, monoclonal (1:200) | Cell Signaling Technology | Cat# 5297 |
| Mouse anti-HB9, monoclonal (1:500) | DSHB | Cat# 81.5C10-c |
| Rabbit anti-Islet1 (ISL1), monoclonal (1:250) | Abcam | Cat# ab109517; RRID: |
| Donkey anti-Mouse IgG (H + L), Alexa Fluor 488 (1:500) | Jackson ImmunoResearch | Cat# 715-545- 150, RRID: |
| Sheep anti-Mouse IgG (H + L), Alexa Fluor 594 (1:500) | Jackson ImmunoResearch | Cat# 515-515-062, RRID: |
| Donkey Anti-Rabbit IgG (H+L), Alexa Fluor 488 (1:500) | Jackson ImmunoResearch | Cat# 711-545-152, RRID: |
| Donkey Anti-Rabbit IgG (H+L), Alexa Fluor 594 (1:500) | Jackson ImmunoResearch | Cat# 711-585- 152, RRID: |
| pRSV-Rev | Addgene | RRID:Addgene_12253 |
| pMDLg/pRRE | Addgene | RRID:Addgene_12251 |
| pMD2.G | Addgene | RRID: Addgene_12259 |
| pCSC-NGN2-IRES-GFP-T2A-Sox11 | Addgene | RRID:Addgene_90214 |
| pCSC-ISL1-T2A-LHX3 | Addgene | RRID:Addgene_90215 |
| 15 mL polystyrene Conical tube | Thermo Fisher Scientific | Cat# 14-959-53A |
| 50 mL polystyrene Conical tube | Thermo Fisher Scientific | Cat# 14-432-22 |
| 24-well cell culture plates | Thermo Fisher Scientific | Cat#142485 |
| 10 cm Cell Culture Dishes | Thermo Fisher Scientific | Cat# 130182 |
| 0.45 μm Sterile Filter Unit (PVDF membrane) | EMD Millipore | Cat# SLHVM33RS |
| 0.22-μm vacuum filter | Millipore | Cat# SLGP033RB |
| HEK293 cell medium | Final concentration | Amount |
|---|---|---|
| Dulbecco’s Modified Eagle Medium (DMEM, 1 | N/A | 44.5 mL |
| Fetal bovine serum (FBS) | 10% | 5 mL |
| Penicillin/Streptomycin (100 | 1% | 0.5 mL |
| Total | N/A | 50 mL |
| Fibroblast medium | Final concentration | Amount |
|---|---|---|
| DMEM | N/A | 42 mL |
| Fetal bovine serum (FBS) | 15% | 7.5 mL |
| Penicillin/Streptomycin (100 | 1% | 0.5 mL |
| Total | N/A | 50 mL |
| Astrocyte medium | Final concentration | Amount |
|---|---|---|
| DMEM | N/A | 42 mL |
| Fetal bovine serum (FBS) | 15% | 7.5 mL |
| Penicillin/Streptomycin (100 | 1% | 0.5 mL |
| Total | N/A | 50 mL |
| Neural induction medium | Final concentration | Amount |
|---|---|---|
| DMEM:F12 (1:1) | N/A | 24 mL |
| Neurobasal media | N/A | 24 mL |
| Penicillin/Streptomycin (100 | 1% | 0.5 mL |
| N2 (100 | 1 | 0.5 mL |
| B27 (50 | 1 | 1 mL |
| FSK (20 mM) | 10 mM | 25 μL |
| DM (10 mM) | 1 mM | 5 μL |
| bFGF (200 μg/mL) | 10 ng/mL | 2.5 μL |
| Total | N/A | 50 mL |
| Neural maturation medium | Final concentration | Amount |
|---|---|---|
| DMEM:F12 (1:1) | N/A | 24 mL |
| Neurobasal media | N/A | 24 mL |
| Penicillin/Streptomycin (100 | 1% | 0.5 mL |
| N2 (100 | 1 | 0.5 mL |
| B27 (50 | 1 | 1 mL |
| FSK (20 mM) | 5 mM | 12.5 μL |
| BDNF (20 μg/mL) | 10 ng/mL | 25 μL |
| GDNF (20 μg/mL) | 10 ng/mL | 25 μL |
| NT3 (20 μg/mL) | 10 ng/mL | 25 μL |
| Total | N/A | 50 mL |
| PEI solution stock | Final concentration | Amount |
|---|---|---|
| PEI (transfection grade, 25 kDa, Linear) | 1 μg/μL | 50 mg |
| MilliQ water | N/A | 50 mL |
| Total | N/A | ∼50 mL |
| Gelatin stock | Final concentration | Amount |
|---|---|---|
| Gelatin | 1 mg/mL | 0.5 g |
| MilliQ water | N/A | 500 mL |
| Total | N/A | 500 mL |
| 10 | Final concentration | Amount |
|---|---|---|
| NaCl | 1.37 M | 80 g |
| KCl | 27 mM | 2.0 g |
| Na2HPO4 | 100 mM | 14.4 g |
| K2HPO4.3H2O | 18 mM | 2.4 g |
| MilliQ water | N/A | ∼950 mL |
| Total | N/A | 1000 mL |